## Abstract High‐resolution magnetic resonance angiography is already a useful tool for studying mouse models of human disease. Magnetic resonance angiography in the mouse is typically performed using time‐of‐flight contrast. In this work, a new long‐circulating blood‐pool contrast agent—a liposoma
High-resolution cerebral blood volume imaging in humans using the blood pool contrast agent ferumoxytol
✍ Scribed by Thomas Christen; Wendy Ni; Deqiang Qiu; Heiko Schmiedeskamp; Roland Bammer; Michael Moseley; Greg Zaharchuk
- Book ID
- 115560357
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 555 KB
- Volume
- 70
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Purpose To evaluate the feasibility of first‐pass contrast‐enhanced magnetic resonance angiography (MRA) using ferumoxytol in humans. ## Materials and Methods First‐pass and equilibrium phase MRA were performed using ferumoxytol in one healthy volunteer and 11 patients with a fast
## Abstract ## Purpose To determine sequence parameters that maximize vascular contrast‐to‐noise (CNR) for ultra‐high resolution equilibrium phase (EP) peripheral imaging for the blood pool agent (BPA) Vasovist. ## Materials and Methods A model for maximizing CNR in EP MR angiography (MRA) is pr
## Abstract The authors suggest that ultra‐small paramagnetic iron oxide (USPIO) particles used as blood pool contrast agents may increase the sensitivity of midfield MRI (i.e., less than 1.5 Tesla) to physiological variations in cerebral blood volume. This hypothesis was tested on a rabbit model o
Arterial cerebral blood volume (CBV a ) is a vital indicator of tissue perfusion and vascular reactivity. We extended the recently developed inflow vascular-space-occupancy (iVASO) MRI technique, which uses spatially selective inversion to suppress the signal from blood flowing into a slice, with a